Implantable electrical devices for prevention of sudden cardiac death: Data on implant rates from a 'real world' regional registry

Europace

Volumn 12, Issue 9, 2010, Pages 1224-1230

  Boriani, Giuseppe ^a   Berti, Elena ^b   Biffi, Mauro ^a   Marino, Massimiliano ^b   Sassone, Biagio ^c   Villani, Giovanni Q ^c   Bottoni, Nicola ^d   Malavasi, Vincenzo L ^e   Melandri, Francesco ^c   Barbato, Gaetano ^f   Talamonti, Ennio ^c   Marconi, Marco ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Agency for Health and Social Care of Emilia Romagna   (Italy)

^c Division of Cardiology   (Italy)

^d Division of Cardiology   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f MAGGIORE HOSPITAL   (Italy)

Author keywords

Guideline; Implantable cardioverter defibrillator; Registry; Sudden death

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DEFIBRILLATOR; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SUDDEN DEATH; TREATMENT INDICATION;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; ITALY; REGISTRIES;

EID: 77956550855     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq176     Document Type: Article

References (27)

1. Ryden L, Stokoe G, Breithardt G, Lindemans F, Potgieter A. Patient access to medical technology across Europe. Eur Heart J 2004;25:611-616
2. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C et al. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007;147:251-262
3. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 2007;297:2502-2514
4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150
5. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1140
6. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace 2006;8:746-837.
7. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 2008;5:e1-62.
8. Al-Khatib SM, Sanders GD, Carlson M, Cicic A, Curtis A, Fonarow GC et al. Preventing tomorrows sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am Heart J 2008;156:613-622
9. Boriani G, Ricci R, Toselli T, Ferrari R, Branzi A, Santini M. Implantable cardioverter defibrillators: from evidence of trials to clinical practice. Eur Heart J Suppl 2007; 9:I66-73.
10. McHale B, Harding SA, Lever NA, Larsen PD. A national survey of clinicians knowledge of and attitudes towards implantable cardioverter defibrillators. Europace 2009;11:1313-1316
11. Ector H, Vardas P, on behalf of the European Heart Rhythm Association European Society of Cardiology. Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association. Eur Heart J Suppl 2007;9:I44-9.
12. Greenberg SM, Epstein AE, Deering T, Goldman DS, Ghidina M, Neason C et al. A comparison of ICD implantations in the United States versus Italy. Pacing Clin Electrophysiol 2007;30:S143-6.
13. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:1-72.
14. Shaw B, Cheater F, Baker R, Gillies C, Hearnshaw H, Flottorp S et al. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2005;3: CD005470.
15. Jamtvedt G, Young JM, Kristoffersen DT, OBrien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2006;2: CD000259.
16. Emilia-Romagna Region Statistics. http://sasweb.regione.emilia-romagna. it/cgibin/broker.exe?-service=stat&-program=prog.selezione.sas&-ds= resident (last accessed 1 April 2010).
17. France G, Taroni F, Donatini A. The Italian health-care system. Health Econ 2005; 14:S187-202.
18. Cunningham AD, Plummer CJ, McComb JM, Lord SW, Cunningham MW, Toussaint JM et al. The implantable cardioverter-defibrillator: postcode prescribing in the UK 1998-2002. Heart 2005;91:1280-1283
19. McComb JM, Plummer CJ, Cunningham MW, Cunningham D. Inequity of access to implantable cardioverter defibrillator therapy in England: possible causes of geographical variation in implantation rates. Europace 2009;11:1308-1312
20. Israel CW. Do some implant too many defibrillators or others too few? Europace 2009;11:982-984
21. Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC et al., GET with the Guidelines Steering Committee Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. J Am Coll Cardiol 2009;53:416-422
22. Mehra MR, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M et al. Evidence of clinical practice heterogeneity in the use of implantable cardioverterdefibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: findings from IMPROVE HF. Heart Rhythm 2009;6:1727-1734
23. Scott PA, Turner NG, Chung A, Morgan JM, Roberts PR. Varying implantable cardioverter defibrillator referral patterns from implanting and non-implanting hospitals. Europace 2009;11:1048-1051
24. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M et al. Heart failure care in the outpatient cardiology practice setting. Findings from IMPROVE HF. Circ Heart Fail 2008;1:98-106.
25. Boriani G, Rapezzi C, Diemberger I, Gonzini L, Gorini M, Lucci D et al. Trialgenerated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome. J Eval Clin Pract 2010; 16:82-91.
26. Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD et al. Review of the ICD Registrys third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm 2009;6:1397-1401
27. Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P et al. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-2007. Europace 2009;11:465-475